These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 17364594

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension.
    Kawecka-Jaszcz K, Czarnecka D, Olszanecka A, Rajzer M, Jankowski P.
    J Hum Hypertens; 2002 Jul; 16(7):509-16. PubMed ID: 12080436
    [Abstract] [Full Text] [Related]

  • 23. Epidemiology of postmenopausal hypertension.
    Sjöberg L, Kaaja R, Tuomilehto J.
    Int J Clin Pract Suppl; 2004 Mar; (139):4-12. PubMed ID: 15117107
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Hypertension in postmenopausal women --selected pathomechanisms].
    Pośnik-Urbańska A, Kawecka-Jaszcz K.
    Przegl Lek; 2006 Mar; 63(12):1313-7. PubMed ID: 17642147
    [Abstract] [Full Text] [Related]

  • 26. A review of the cardiovascular and breast actions of drospirenone in preclinical studies.
    Simoncini T, Genazzani AR.
    Climacteric; 2010 Feb; 13(1):22-33. PubMed ID: 19938948
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Hormone replacement therapy and cardiovascular risk in menopausal women].
    Simon T, Jaillon P.
    Arch Mal Coeur Vaiss; 2001 Feb; 94(2):132-8. PubMed ID: 11265551
    [Abstract] [Full Text] [Related]

  • 29. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A, De Leo V.
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. HRT and cardiovascular disease.
    Stevenson JC.
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):109-20. PubMed ID: 19095500
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women.
    Karara AH, Hanes V, Alonso A, Ni P, Poola N, Silang R, Blode H, Preston RA.
    J Clin Pharmacol; 2007 Oct; 47(10):1292-302. PubMed ID: 17906162
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group.
    Hum Reprod Update; 2006 Oct; 12(5):483-97. PubMed ID: 16807276
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
    L'hermite M, Simoncini T, Fuller S, Genazzani AR.
    Maturitas; 2008 Oct; 60(3-4):185-201. PubMed ID: 18775609
    [Abstract] [Full Text] [Related]

  • 40. Effects of hormone therapy on blood pressure and the renin-angiotensin system in postmenopausal women.
    Prime DD, Brosnihan KB, Herrington DM.
    Minerva Cardioangiol; 2007 Aug; 55(4):477-85. PubMed ID: 17653023
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.